Details for: MULTI VITAMINS AND MINERALS

Product description

Product name: MULTI VITAMINS AND MINERALS

Company name: SUTRA HEALTH SYSTEMS CANADA

DIN: 00639303

Status: Cancelled Post Market

Status date: 1996-12-12

Active ingredient(s)	Strength
ASCORBIC ACID	125 MG / CAP
BETA-CAROTENE	2500 UNIT / CAP
BIOTIN	75 MCG / CAP
CALCIUM (CALCIUM PHOSPHATE (DIBASIC))	100 MG / CAP
CHROMIUM HVP CHELATE	25 MCG / CAP
FOLIC ACID	.2 MG / CAP
IODINE (KELP)	.0375 MG / CAP
IRON (FERRIC AMMONIUM CITRATE)	4.5 MG / CAP
MAGNESIUM HVP CHELATE	75 MG / CAP
MANGANESE HVP CHELATE	5 MG / CAP
NICOTINAMIDE	25 MG / CAP
NICOTINIC ACID	6.25 MG / CAP
POTASSIUM CHLORIDE	24.75 MG / CAP
PYRIDOXINE HYDROCHLORIDE	18.75 MG / CAP
SELENIUM (SODIUM SELENITE)	25 MCG / CAP
THIAMINE HYDROCHLORIDE	12.5 MG / CAP
VITAMIN B12	5 MCG / CAP
VITAMIN B2	12.5 MG / CAP
VITAMIN D	75 UNIT / CAP
VITAMIN E (D-ALPHA TOCOPHERYL ACID SUCCINATE)	50 UNIT / CAP
ZINC (ZINC SULFATE)	5 MG / CAP

Click on a resource to visit a page with more information. You may be taken away from this page to a different Government of Canada website.

For consumers

Resource	Description
Report a side effect	Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are: Unexpected, regardless of their severity, i.e., not consistent with product information or labelling; or Serious, whether expected or not, i.e., that requires being admitted to the hospital, lengthened hospital stay, causes a birth defect, disability, is life-threatening or results in death; Reactions to recently marketed health products (on the market for less than five years), regardless of their nature or severity.

For health care professionals

Resource	Description
Report a serious adverse drug reaction (for hospitals)	Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals.

For researchers

Resource	Description
Search Clinical Information	After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.

All resources

Resource	Description
Search Clinical Information	After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.
Report a side effect	Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are: Unexpected, regardless of their severity, i.e., not consistent with product information or labelling; or Serious, whether expected or not, i.e., that requires being admitted to the hospital, lengthened hospital stay, causes a birth defect, disability, is life-threatening or results in death; Reactions to recently marketed health products (on the market for less than five years), regardless of their nature or severity.
Report a serious adverse drug reaction (for hospitals)	Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals.

Resource	Description
Report a side effect	Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are: Unexpected, regardless of their severity, i.e., not consistent with product information or labelling; or Serious, whether expected or not, i.e., that requires being admitted to the hospital, lengthened hospital stay, causes a birth defect, disability, is life-threatening or results in death; Reactions to recently marketed health products (on the market for less than five years), regardless of their nature or severity.

Resource	Description
Search Clinical Information	After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.

Resource	Description
Search Clinical Information	After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.

Resource	Description
Search Clinical Information	After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.
Report a side effect	Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are: Unexpected, regardless of their severity, i.e., not consistent with product information or labelling; or Serious, whether expected or not, i.e., that requires being admitted to the hospital, lengthened hospital stay, causes a birth defect, disability, is life-threatening or results in death; Reactions to recently marketed health products (on the market for less than five years), regardless of their nature or severity.
Report a serious adverse drug reaction (for hospitals)	Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals.